Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CRSNASDAQ:INOV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRSCarpenter Technology$230.23+1.9%$193.16$95.17▼$236.59$11.46B1.33763,109 shs886,496 shsINOVInovalon$31.540.0%$40.92$17.56▼$41.06$4.90B0.53720,587 shs1,486 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRSCarpenter Technology0.00%-0.88%+15.76%+17.93%+113.45%INOVInovalon-0.01%+0.41%+3.82%+5.04%+10.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRSCarpenter Technology3.6489 of 5 stars1.41.01.70.04.12.53.8INOVInovalon0.8676 of 5 stars0.00.00.04.30.01.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRSCarpenter Technology 2.83Moderate Buy$168.00-27.03% DownsideINOVInovalon 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PBLT, INOV, SQN, and CRS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CRSCarpenter TechnologyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$240.00 ➝ $245.004/9/2025CRSCarpenter TechnologyNorthcoast ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeSell ➝ Neutral(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRSCarpenter Technology$2.92B3.92$8.64 per share26.65$34.37 per share6.70INOVInovalon$667.52M7.34$0.95 per share33.35$4.94 per share6.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRSCarpenter Technology$186.50M$7.0643.4428.490.939.34%19.88%9.92%7/24/2025 (Estimated)INOVInovalon$22.58M$0.3492.7847.082.996.73%10.97%4.10%N/ALatest PBLT, INOV, SQN, and CRS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025Q3 2025CRSCarpenter Technology$1.74$1.88+$0.14$1.88$729.67 million$727.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRSCarpenter Technology$0.800.35%N/A11.33%N/AINOVInovalonN/AN/AN/AN/AN/ALatest PBLT, INOV, SQN, and CRS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/10/2025CRSCarpenter Technologyquarterly$0.200.48%4/22/20254/22/20256/5/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRSCarpenter Technology0.403.801.92INOVInovalon1.172.402.40Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRSCarpenter Technology92.03%INOVInovalon33.15%Insider OwnershipCompanyInsider OwnershipCRSCarpenter Technology2.90%INOVInovalon49.75%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRSCarpenter Technology4,10049.78 million48.50 millionOptionableINOVInovalon1,836155.25 million78.01 millionNo DataPBLT, INOV, SQN, and CRS HeadlinesRecent News About These CompaniesPatients with eosinophilic esophagitis face economic burdensMay 23 at 7:38 PM | healio.comEd Chidsey Appointed President of Inovalon’s Insights Business UnitMay 22 at 10:27 AM | finance.yahoo.comInovalon Optimizes Multicloud Network Operations Management with Aviatrix®May 20, 2025 | finance.yahoo.comKarly Rowe Appointed as President of Inovalon’s Provider Business UnitMay 15, 2025 | finance.yahoo.comInovalon Earns 2025 Great Place To Work® Certification™ For Third Consecutive YearMay 6, 2025 | finance.yahoo.comConcertAI Announces Leadership Transition to Accelerate AI Innovation and GrowthMay 1, 2025 | finance.yahoo.comMaryland’s 11 billionaires include founders of Under Armour, Squarespace, Inovalon: ForbesApril 22, 2025 | msn.comFormer Inovalon Exec, Michael Hasbany, Joins HealthmineApril 22, 2025 | businesswire.comInovalon Adds Safety Management to the PointClickCare MarketplaceApril 1, 2025 | tmcnet.comDetermining the Effectiveness of Decentralization Across Different TrialsMarch 20, 2025 | appliedclinicaltrialsonline.comThe Role of Quality Data in Utilizing Machine Learning ModelsMarch 19, 2025 | appliedclinicaltrialsonline.comImplementing Technology into Clinical Operations WorkflowsMarch 18, 2025 | appliedclinicaltrialsonline.comModernizing Patient RecruitmentMarch 17, 2025 | appliedclinicaltrialsonline.comInovalon Enters Next Chapter of Innovation and Transformation Led by New CEO, Adam KanslerMarch 4, 2025 | finance.yahoo.comInovalon’s Patient Payment Solutions Are Now Available on the PointClickCare MarketplaceFebruary 27, 2025 | finance.yahoo.comInovalon's Patient Payment Solutions Are Now Available on the PointClickCare MarketplaceFebruary 27, 2025 | businesswire.comInovalon introduces AI-powered platform to expedite clinical trial recruitmentFebruary 26, 2025 | finance.yahoo.comInovalon Launches Clinical Research Patient Finder to Accelerate Trial RecruitmentFebruary 25, 2025 | finance.yahoo.comInovalon Launches Clinical Research Patient Finder to Accelerate Trial RecruitmentFebruary 25, 2025 | businesswire.comReal-World Muscle-Invasive Bladder Cancer Treatment Patterns RevealedFebruary 19, 2025 | renalandurologynews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePBLT, INOV, SQN, and CRS Company DescriptionsCarpenter Technology NYSE:CRS$230.22 +4.23 (+1.87%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$229.96 -0.27 (-0.12%) As of 05/23/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves to aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.Inovalon NASDAQ:INOVInovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver This Market Sell-Off Might Trigger a Value Rotation Into Pepsi Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
